Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer
Clinical trial NCT00525161 · TERMINATED
Trial details
- NCT number
- NCT00525161
- Sponsor
- Suleiman Massarweh
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2013-01-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.